Growth Metrics

LifeMD (LFMD) Gains from Investment Securities (2016 - 2025)

LifeMD filings provide 13 years of Gains from Investment Securities readings, the most recent being $104529.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 133.48% to $104529.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 million, a 1.07% increase, with the full-year FY2025 number at $60000.0, down 33.33% from a year prior.
  • Gains from Investment Securities hit $104529.0 in Q4 2025 for LifeMD, up from $30000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $2.0 million in Q3 2022 to a low of -$2.6 million in Q4 2022.
  • Median Gains from Investment Securities over the past 5 years was $563000.0 (2022), compared with a mean of $556830.8.
  • Biggest five-year swings in Gains from Investment Securities: crashed 257.59% in 2022 and later soared 1281.01% in 2024.
  • LifeMD's Gains from Investment Securities stood at $1.7 million in 2021, then crashed by 257.59% to -$2.6 million in 2022, then soared by 138.51% to $1.0 million in 2023, then crashed by 131.02% to -$312249.0 in 2024, then skyrocketed by 133.48% to $104529.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $104529.0 (Q4 2025), $30000.0 (Q3 2025), and $220000.0 (Q2 2025) per Business Quant data.